Seen through an investor's lens, dentistry is two markets that look like different stories but run on the same set of digital tools — one side is the implant, the titanium post that replaces a tooth lost to age, a market growing quietly on the aging wave. The other is the clear aligner, the Invisalign-style clear plastic tray that the young will pay thousands for the sake of looks, a market growing ~27% a year. And what stitches the two sides together is the intraoral scanner and CAD/CAM, which turns a putty mouth-impression into a 3D file in seconds.
Contains
Theme index· base 100 · USD total return
News & notes movingDental & Clear Aligners
Thailand
Dental & Clear Aligners11
Dental Corporation, or D, moves from mai to trade on SET on October 1, 2026
Dental Corporation Public Company Limited, or D, has met the criteria of the Stock Exchange of Thailand and will move from the Market for Alternative Investment, or mai, to trade on the SET in the Services industry group, Medical business sector, starting October 1, 2026, after more than 9 years listed on mai. Chief Executive Officer Pornsak Tantapakul, together with the company's board and executives, joined in congratulating the occasion. The company stated that the move to the SET reflects the organization's growth and potential, from its beginnings as a Thai family business to a listed company in the capital market, and that over the past 9 years it has used funds raised to expand its business, generating growth in revenue, net profit, and shareholders' equity. The Dental Corporation group operates a full-service dental business, covering dental hospitals, the Bangkok International Dental Hospital, or BIDH, dental centers, Smile Signature dental clinics, and Dental Planet dental clinics, as well as Dental Vision Company Limited, a subsidiary that distributes dental materials and equipment.
Aging Population › Hearing / Vision / Dental ▲Capital
Aging Population › Dental & Clear Aligners Capital
D.BK · Capital · Positive Dental Corporation moves from mai to trade on the SET, reflecting its growth in revenue, net profit, and shareholders' equity.
CVS Health Raises 2026 Revenue and Earnings Guidance
CVS Health now projects 2026 revenues of at least $414 billion, up from its earlier projection of at least $405 billion, and boosted adjusted earnings guidance to $7.90-$8.10 from $7.30-$7.50. The company said it still faces reimbursement pressure across its government, retail pharmacy and PBM businesses, and that the 2027 Medicare Advantage payment update is insufficient to fully offset underlying medical cost trends. In the second quarter, same-store front-store sales rose just 1% year over year, while the Pharmacy & Consumer Wellness segment's growth was offset by regulatory-related price reductions, generic introductions and pharmacy reimbursement pressure. In a peer update, Align Technology recorded an estimated $37.5 million liability, including interest, after the U.K. Upper Tribunal in July 2026 overturned the prior VAT-exemption ruling for clear aligners, and will apply 20% VAT to applicable U.K. Invisalign aligners and Vivera retainers from Sept. 7, 2026, without changing list prices. Cardinal Health said a prolonged conflict in Iran could move its Global Medical Products and Distribution segment toward the lower end of its $200 million to $220 million segment profit range.
Aging Population › Dental & Clear Aligners ▼Regulation
CVS · Capital · Positive CVS raised its 2026 revenue guidance to at least $414 billion and adjusted EPS guidance to $7.90-$8.10.
ALGN · Regulation · Negative U.K. Upper Tribunal overturned the VAT-exemption ruling for clear aligners, imposing 20% VAT on applicable U.K. Invisalign aligners and Vivera retainers, creating an estimated $37.5 million liability.
CAH · Geopolitics · Negative A prolonged conflict in Iran could push its Global Medical Products and Distribution segment toward the lower end of its $200-220 million profit range.
Dental Services Market to Reach USD 596.85 Billion by 2032
The global dental services market is projected to reach USD 425.56 billion in 2026 and grow at a compound annual growth rate of 5.65% to hit USD 596.85 billion by 2032, according to a new report from ResearchAndMarkets.com. The sector spans general dentistry, orthodontics, periodontics, prosthodontics, endodontics, oral surgery, pediatric dentistry, cosmetic dentistry, dental diagnostics, and maintenance services delivered through private practices, group practices, dental service organizations, public health systems, hospitals, and academic clinics. Demand is supported by the high global burden of oral diseases, aging populations, increasing awareness of preventive care, rising adoption of dental implants and clear aligners, and the growing link between oral health and systemic conditions such as diabetes, cardiovascular disease, respiratory infection risk, and adverse pregnancy outcomes. The World Health Organization estimates that oral diseases affect 3.5 billion people worldwide, making access to affordable, timely, and quality dental care a core public health priority. The report highlights transformative shifts including digital dentistry, teledentistry, artificial intelligence, minimally invasive procedures, and value-based care models, while noting persistent barriers such as uneven insurance coverage, workforce shortages in rural areas, and disparities in pediatric and geriatric oral healthcare access.
Thailand
